zinc dtpa
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2016 (NCT02947022)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- ZincSupplementation
Zinc supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- zinc dtpa
- zinc dtpa
- zinc dtpa
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05359835 | Early Phase 1 (Phase 1) | Dec 15, 2022 | Stanford University |
| NCT02947022 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2016 | Hameln Pharma GmbH, University of North Carolina at Chapel Hill |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hameln Pharma GmbH | For profit | 1 | 0 | 1 | 2016 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| University of North Carolina at Chapel Hill | Academic/Hospital | 1 | 1 | 1 | 2016 |
3 organizations
Page 1 / 1